Results 111 to 120 of about 115,969,812 (153)
Tripeptidyl-Peptidase II: A Multi-Purpose Peptidase
Tripeptidyl-peptidase II is a high-molecular weight peptidase with a widespread distribution in eukaryotic cells. The enzyme sequentially removes tripeptides from a free N-terminus of longer peptides and also displays a low endopeptidase activity. A role
Ann-Christin Lindås, Birgitta Tomkinson
exaly +9 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Biological Chemistry, 2019
Incidental detection of pancreatic cysts has increased dramatically over the last decade, but risk stratification and clinical management remain a challenge.
S. Ivry +8 more
semanticscholar +3 more sources
Incidental detection of pancreatic cysts has increased dramatically over the last decade, but risk stratification and clinical management remain a challenge.
S. Ivry +8 more
semanticscholar +3 more sources
Toxicology and Applied Pharmacology, 2014
CLN2 disease is caused by deficiency in tripeptidyl peptidase-1 (TPP1), leading to neurodegeneration and death. The safety, pharmacokinetics (PK), and CNS distribution of recombinant human TPP1 (rhTPP1) were characterized following a single intracerebroventricular (ICV) or intrathecal-lumbar (IT-L) infusion to cynomolgus monkeys. Animals received 0, 5,
Brian R. Vuillemenot +9 more
semanticscholar +4 more sources
CLN2 disease is caused by deficiency in tripeptidyl peptidase-1 (TPP1), leading to neurodegeneration and death. The safety, pharmacokinetics (PK), and CNS distribution of recombinant human TPP1 (rhTPP1) were characterized following a single intracerebroventricular (ICV) or intrathecal-lumbar (IT-L) infusion to cynomolgus monkeys. Animals received 0, 5,
Brian R. Vuillemenot +9 more
semanticscholar +4 more sources
Metabolic Brain Disease
Neuronal ceroid-lipofuscinosis (NCLs) are a group of severe neurodegenerative conditions, most likely present in infantile, late infantile, juvenile, and adult-onset forms. Their phenotypic characteristics comprise eyesight damage, reduced motor activity and cognitive function, and sometimes tend to die in the initial stage.
P. K. +3 more
semanticscholar +3 more sources
Neuronal ceroid-lipofuscinosis (NCLs) are a group of severe neurodegenerative conditions, most likely present in infantile, late infantile, juvenile, and adult-onset forms. Their phenotypic characteristics comprise eyesight damage, reduced motor activity and cognitive function, and sometimes tend to die in the initial stage.
P. K. +3 more
semanticscholar +3 more sources
Clinica Chimica Acta, 2019
PURPOSE CLN2 disease is a genetic disorder caused by dysfunction of the lysosomal enzyme tripeptidyl peptidase 1 (TPP1) that belongs to the neuronal ceroid lipofuscinoses (NCL) and leads to epilepsy, dementia, and death in young persons. CLN2 disease has
Z. Lukács +6 more
semanticscholar +3 more sources
PURPOSE CLN2 disease is a genetic disorder caused by dysfunction of the lysosomal enzyme tripeptidyl peptidase 1 (TPP1) that belongs to the neuronal ceroid lipofuscinoses (NCL) and leads to epilepsy, dementia, and death in young persons. CLN2 disease has
Z. Lukács +6 more
semanticscholar +3 more sources
Molecular Genetics and Metabolism, 2011
Late infantile neuronal ceroid lipofuscinosis (LINCL) is caused by mutations in the gene encoding tripeptidyl-peptidase 1 (TPP1). LINCL patients accumulate lysosomal storage materials in the CNS accompanied by neurodegeneration, blindness, and functional decline.
Brian R. Vuillemenot +14 more
semanticscholar +3 more sources
Late infantile neuronal ceroid lipofuscinosis (LINCL) is caused by mutations in the gene encoding tripeptidyl-peptidase 1 (TPP1). LINCL patients accumulate lysosomal storage materials in the CNS accompanied by neurodegeneration, blindness, and functional decline.
Brian R. Vuillemenot +14 more
semanticscholar +3 more sources
Tripeptidyl-peptidase 1 in neuronal ceroid lipofuscinoses and other lysosomal storage disorders
European Journal of Paediatric Neurology, 2001The classic late infantile form of neuronal ceroid lipofuscinosis (CLN2, cLINCL) is associated with mutations in the gene encoding tripeptidyl-peptidase I (TPP-I), a lysosomal aminopeptidase that cleaves off tripeptides from the free N-termini of oligopeptides.
K. Wisniewski +5 more
semanticscholar +2 more sources
Molecular Genetics and Metabolism, 2019
CLN2 disease is a lysosomal storage disorder that belongs to the neuronal ceroid lipofuscinoses (NCL) and progressively leads to dementia, blindness and early death. It is caused by a deficiency of the lysosomal enzyme tripeptidyl peptidase 1 (TPP1). The
Z. Lukács +6 more
semanticscholar +2 more sources
CLN2 disease is a lysosomal storage disorder that belongs to the neuronal ceroid lipofuscinoses (NCL) and progressively leads to dementia, blindness and early death. It is caused by a deficiency of the lysosomal enzyme tripeptidyl peptidase 1 (TPP1). The
Z. Lukács +6 more
semanticscholar +2 more sources

